v" Hematoporphyrin derivative (HPD) is a photosensitizing agent that has been used to locate and kill tumors. The distribution of tritiated (3H)-HPD was studied in a transplantable canine glioma model following intraperitoneal or direct intraneoplastic injection. Compared to intraperitoneal adminstration of 3H-HPD, direct injection resulted in levels that were more than 2.5 times higher in tumor tissue and approximately l0 times lower in skin. Dose-corrected analysis of the data indicated that outside the central nervous system (CNS) the distribution of 3H-HPD is dose-related, regardless of route of injection. Within the CNS, direct injection leads to more efficient uptake of 3H-HPD, especially at the tumor periphery. Fluorescence microscopy confirmed the selective biodistribution of HPD fluorescence within the cytoplasm of tumor cells.
T HE selective biodistribution of the photosensitizer hematoporphyrin derivative (HPD) is well known in a wide range of neoplastic, embryonic, and regenerating tissues? '3'~ 1,~6 Intracellular HPD can be activated by light of the appropriate wavelength (630 nm), yielding a cytotoxic effect mediated by the production of singlet oxygen, hydroxyl radicals, and superoxygen. 7,2~ This process has been termed "photoradiotherapy. ''2 Clinical trials utilizing intravenously administered HPD have been tried in the treatment of human malignant brain tumors. Photodynamic killing, as evidenced by tumor-cell necrosis, has been seen, albeit in the absence of improved survival. ~~ Cutaneous phototoxicity has been the major side effect limiting the use of higher HPD doses. To obtain increased tumor concentrations of HPD and to minimize systemic toxicity following parenteral administration of the dye, Kostron, et al.,9 attempted direct intraneoplastic injection into subcutaneous and intracranial tumors in the rat glioma model. The results indicated that intraneoplastic injection was superior to intraperitoneal injection for increasing tumor concentrations of HPD, and also decreased HPD concentrations in surrounding brain, in the skin, and in other normal tissues. Furthermore, the elevated HPD concentrations in tumor were found to correlate with an increased cytotoxic effect, both in vitro and in vivo.
To study both the qualitative and quantitative aspects of HPD concentrations in a tumor system more closely resembling human malignant brain tumors, we utilized the modified canine glioma model of Salcman, et al., 19 in our present investigation. The canine glioma is a fatal, rapidly growing tumor with many of the histological characteristics of human glioblastoma, including capillary proliferation, pseudopallisading, frequent mitotic figures, and multinucleated giant cells. In addition, the tumor system lends itself well to radiological evaluation and surgical manipulation, thus rendering it an appropriate model for studying HPD photoradiotherapy as a potential treatment of malignant brain tumors.
Materials and Methods
The modified transplantable canine glioma model 19 was used in this investigation. Frozen tumor brei* was thawed and grown in tissue culture. At passage 6, the cells of three confluent tissue culture flasks were concentrated into an injectable 1-cc tumor cell suspension of 3.1 • 10 v cells/cc. The 0.1-cc cell suspension followed by 0.1 cc of air was injected to a depth of 0.8 cm through the left lateral corner of the anterior fontanel of each puppy in a litter of neonatal beagles (12 to 48 hours old). All injections were performed under sterile conditions. After injection, the animals remained active and healthy and were returned to their mother.
On postinjection Days 10 to 14, the animals were sacrificed and tumor brei was harvested for frozen storage, tissue culture, and histological verification. Tumor was prepared for frozen storage by mincing it into submillimeter pieces, followed by fine grinding in a tissue-grinding tube containing culture medium. After coarse straining through a gauze sponge, viability was assessed by exclusion of trypan blue, and 2-cc aliquots were frozen at -60~ For subsequent injections into neonatal beagles, a vial of the frozen tumor brei was thawed in a 35~ water bath and immediately injected through the left lateral corner of the anterior fontanel as described above.
Tritiated (3H)-HPD was prepared from HPD-diacetate (solid) by catalytic exchange labeling.t An aliquot of the labeled preparation (Lot No. 2107-164), with a specific activity of 1.2 mCi/mg, was obtained for use in our study. The acetylated form of 3H-HPD was then treated by the modified Lipson formula? 1 yielding an injectable 5-mg/cc solution as follows. The chloroformmethanol solvent was evaporated off with nitrogen gas. The solid HPD-diacetate was alkali-treated by dissolving it in 0.1 N NaOH, followed by neutralization of the solution 1 hour later to a physiological pH of approximately 7.4 with 0.1 N HCh The solution was then diluted with 0.9% NaC1 to a concentration of 5 mg/cc; subsequent millipore filtration yielded a sterile injectable solution.
To study direct intraneoplastic injection, 1.00 mg 3H-HPD/cu cm tumor volume was injected 1 cm deep into the tumors of six neonatal beagles. Since the tumor brei was injected at 0.8 cm, the additional 0.2 cm was calculated to allow for skull and brain growth during the intervening period. Tumor volume was estimated to be the average of 1.34 and 2.14 cu cm, volumes that represent the range of tumor sizes on the 9th and 10th days postinoculation, as reported by Salcman, et al. 19 Hence, for animals treated with direct intraneoplastic injection, 1.75 mg 3H-HPD was delivered in a volume of 0.35 cc.
To compare parenteral injection of 3H-HPD to direct intraneoplastic injection, a second group of five neonatal beagles were injected intraperitoneally with 25 mg 3H-HPD/kg body weight. All 3H-HPD injections, for both the intraneoplastic and intraperitoneal groups, were performed 10 days after the injection of tumor brei. At 48 hours after injection of 3H-HPD all animals were sacrificed, and tissue samples were dissected, rinsed with saline, weighed, and prepared for scintillation counting.
t Hematoporphyrin-diacetate obtained from Photofrin Medical, Inc., Cheektowaga, New York; catalytic exchange labeling performed by New England Nuclear, Boston, Massachusetts.
Quantitative analysis of 3H-HPD distribution was studied in both tumor and normal tissues. After rinsing with normal saline, the tissue samples were weighed on an analytical balance, dissolved in Protosol,z~ and bleached with H202. Econofluor (10 cc) was added to the completely dissolved samples, which were counted in a Beckman LS 230 scintillation counter.w The 3H-HPD content was calculated by converting counts per minute/gm wet tissue weight to mCi/gm. Data are reported both in absolute terms (mCi/gm) and in relative terms (mCi/gm tissue/mCi 3H-HPD injected), thereby correcting for the dosage variation between direct and intraperitoneat routes of administration. All data are expressed as the mean value and standard deviation, with significance being determined by the paired Student t-test.
Coronal brain sections through the frontoparietal tumor were photographed with Kodak ASA 400 daylight film before being prepared by conventional histological methods. Some of the preparations were stained for histological examination, while unstained samples were used for fluorescence microscopy. For fluorescence microscopy, sections 5-u thick were examined with a Zeiss Orthoplan microscopell using a 405-nm excitation beam (G405 filter) with a red-fluorescence detection filter (LP590).
Results
Tumor growth was evident in specimens from all animals, and gross visualization of HPD content and distribution was possible with a Wood's lamp (Fig. 1) . In both intraperitoneally and directly injected animals, fluorescence was seen in the choroid plexus as well as in the tumor.
The six animals with intracerebral tumors that were directly injected with 1.75 mg (0.098 mCi) of 3H-HPD exhibited no apparent adverse effects (Table 1 ). In tissue samples from these dogs the average content of 3H-HPD was 1.84 mCi/gm wet tissue weight at the tumor center and 6.72 mCi/gm at the tumor periphery. The edematous brain adjacent to the tumor contained 0.98 mCi/gm, a value comparable to that of the normal ipsilateral and contralateral brain tissue. The mean 3H-HPD content in the skin of these six animals was 0.08 mCi/gm. In the one sample of choroid plexus studied, the 3H-HPD value was 18.21 mCi/gm.
The five animals that were injected intraperitoneally with 25 mg 3H-HPD/kg body weight demonstrated an average 3H-HPD value of 1.90 mCi/gm wet tissue at the tumor center and 2.55 mCi/gm at the tumor periphery. The edematous brain contained 1.06 mCi/gm, Protosol manufactured by New England Nuclear, Boston, Massachusetts.
w Econofluor manufactured by New England Nuclear, Boston, Massachusetts; scintillation counter manufactured by Beckman Instruments, Palo Alto, California.
II Orthoplan microscope manufactured by Carl Zeiss, Inc., Thornwood, New York. 
3H-HPD content of intracerebral tumors and normal tissues'
48 hours after injection* while normal brain tissues had comparable values. The skin contained 0.91 mCi/gm. In the one choroid plexus sample, the 3H-HPD value was 4.97 mCi/gm. For the doses tested, the 3H-HPD levels in edematous and normal brain were not significantly different between the two routes of administration. In contrast, the 3H-H P D content was significantly higher (p < 0.05) in the periphery of tumors injected directly than in the periphery of tumors injected intraperitoneally.
To correct for variations in the original dosages administered to each group, mCi/gm wet tissue weight * Values are in mCi/gm wet tissue weight, to correct for variations in the original dosages of tritiated hematoporphyrin derivative (3H-HPD) administered to each group of dogs; values were divided by 0.098 mCi and an average of 1.12 mCi for animals undergoing direct or intraperitoneal (IP) injection. Derived from data in Table 1. values were divided by 0.098 mCi and an average of 1.12 mCi for directly injected and intraperitoneally injected animals, respectively ( Table 2 * 3H-HPD = tritiated hematoporphyrin derivative; IP = intraperitoneal. For a description of the method of determining uptake see Table 2 .
in other areas of normal brain were comparable to those for edematous brain.
Overall, direct intraneoplastic injection of 3H-HPD resulted in a 2.82-fold enhancement in the ratio of tumor periphery to edematous brain when compared to intraperitoneal administration (Table 3) . Direct injection increased the tumor periphery to skin ratio 30-fold. Fluorescence microscopy confirmed the selective biodistribution of fluorescence within tumor tissue. Not only was fluorescence clearly localized within tumorcell cytoplasm and possibly the cell membranes (Fig.  2) , but it also revealed clearly demarcated borders between normal and tumor tissue and demonstrated small tumor "fingers" within normal brain tissue in both the intraperitoneal and direct injection groups.
Discussion
The selective biodistribution of HPD in malignant tumors, coupled with the photodynamic cytotoxic effect, offers a unique approach to the therapy of malignant brain tumors. To date, all human studies have utilized intravenously administered HPD. Although these clinical studies have been promising in terms of computerized tomography evidence for tumor shrinkage and histological evidence for tumor necrosis, there has been no improvement in survival time. ~~ Our hypothesis has been that direct intraneoplastic injection can increase the HPD concentration within the tumor while decreasing it systemically. The idea of direct injection is not new. It has been used with such compounds as radioisotopes and various cytostatic agents in an attempt to circumvent the blood-brain barrier, minimize systemic toxicities, and increase tumor drug concentrations.12'15'22 What makes HPD different from these other compounds is its selective binding activity. Thus, the theoretical advantage of maximizing the HPD concentration in the immediate tumor environment is to alter the equilibrium between bound and unbound forms of HPD, thereby favoring increased tissue binding. The increased tissue concentrations of HPD would then result in increased light-activated cytotoxicity. Prior studies of HPD distribution and cytotoxicity in a rat tumor model lend support to this idea?
The objective of the current study was to examine the distribution characteristics of HPD in an experimental brain-tumor model that not only more closely resembles human malignant brain tumors than does the rat tumor model but also allows for future radiological and surgical experiments. The canine glioma model is ideal for this purpose.
Tritiated-HPD and scintillation counting were used to quantify HPD tissue concentrations in our present experiment. In 1979, Gomer and Dougherty 4 reported the use of tritium (3H)-and carbon-14 (~4C)-labeled HPD for studying the distribution of porphyrins in tissues. Incorporation of [2-~4C]-glycine into the stable heine ring structure and 3H labeling of HPD by the technique of catalytic exchange allowed these investi-gators to compare the characteristics of HPD, 14C-HPD, and 3H-HPD and to obtain reliable reproducible distribution data. Their results showed no difference among these three forms of HPD with respect to absorption spectra, chromatographic pattern, biological activity, or in vivo tissue distribution. Thus, significant in vivo exchange of 3H is not likely, thereby rendering 3H-HPD a reliable marker for distribution studies. The data also demonstrated that gross visualizations of fluorescence and actual tissue concentrations of the dye, as determined by scintillation counting, do not correlate. The discrepancies between the results obtained by quantitative fluorescence microscopy and by scintillation spectrometry may be due to fluorescence quenching associated with porphyrin aggregation and protein binding. 17 However, Wharen, et al., 23 have recently reported a reproducible method of quantitating the amount of HPD in specimens that bypasses the problem of significant quenching by determining fluorescence at -12~ This method may be useful for quantifying concentrations of HPD in brain and other nonpigmented tissues in humans where one would not want to use radioisotopes.
In the canine glioma model, we chose to compare direct injection of 1 mg 3H-HPD/cu cm tumor volume to an increased intraperitoneal dose of 25 mg 3H-HPD/ kg body weight rather than to the 10-mg/kg body weight intraperitoneal dose used in our previous experiment. 9 The average animal undergoing direct injection received 1.75 mg 3H-HPD, while the average intraperitoneally injected animal received 20 mg 3H-HPD. Despite this marked difference, there was an impressive increase in the absolute tumor concentration of 3H-HPD in the directly injected dogs.
The most significant enhancement of absolute 3H-HPD concentration with direct injection occurred at the peripheral portion of the tumor. The concentration of HPD in edematous brain, however, did not differ significantly between the two modes of injection. Therefore, direct injection resulted in a 2.8-fold enhancement of 3H-HPD uptake at the tumor periphery compared to edematous brain (Table 3) . These higher 3H-HPD concentrations at the tumor periphery are consistent with the findings of other investigators 9,11 and may reflect increased tumor uptake by the most active portion of the tumor. At least three "metabolic zones" have been identified in model tumor systems. 8 The central portion of the glioblastoma tends to be more hypoxic and necrotic, whereas the intermediate and peripheral zones exhibit increasingly higher rates of oxygen consumption and higher percentages of actively dividing cells. The relatively low growth fraction of the tumor as a whole (30%), despite its rapid potential doubling time (7 to 8 days), implies that the growing margin is extremely aggressive. 5' 6' 18 Studies by Moan, et aL, ~2 suggest that there is only a moderate increase in cellular binding of HPD in ceils of increasing malignancy, and that the increase may be accounted for by the increased surface area:volume ratio characteristics of more rapidly dividing cell populations. 2~ Nonetheless, increased HPD uptake at this level will theoretically maximize the benefits of photoradiotherapy if HPD tissue concentrations correlate with cytotoxic potential in canine and human tissues in the same manner as they do in rat glioma tissue.
The necrotic tumor center and primary tumor bulk are easily resected at craniotomy. However, regardless of how meticulous the resection, microscopic infiltration by tumor "fingers" and tumor islands is invariably present. 2~ An encouraging observation is that the tumor "fingers" and islands showed intense discrete fluorescence as compared to normal surrounding brain, when observed with the fluorescence microscope. The fluorescence was located in the cytoplasm and possibly the cellular membranes (Fig. 2) . Thus, phototherapy with HPD may optimally be utilized to kill the infiltrating cells that remain after surgery.
In addition to the improvement in the tumor periphery:edematous brain HPD concentration ratio, direct injection results in a tumor periphery:skin therapeutic ratio that is 30 times better than that obtained with intraperitoneal injection (Table 3) . Because increased HPD concentrations in skin correlate with increased porphyria-like skin phototoxicities, zl direct injection should be helpful in reducing the primary side effect associated with its use.
It is of interest that the choroid plexus exhibits 3H-HPD uptake superior to that of any other tissue, including tumor periphery, for both direct and intraperitoneal injection. Furthermore, the dose-corrected values indicate that direct injection leads to about a 40-fold increase in uptake efficiency over the intraperitoneal route of administration. This may be relevant in the elucidation of mechanisms of HPD uptake and/or in the clinical treatment of hydrocephalus by ablation of the choroid plexus after ventricular insertion of a light source.
Summary
We have shown in a canine glioma model that direct intraneoplastic injection of HPD produces higher levels of HPD at the tumor periphery relative to brain, skin, and other organs when compared with parenteral administration. Because intraneoplastic injection was well tolerated and produced maximal HPD concentration in the infiltrating islands of tumor, we believe that this technique should be further evaluated as a therapeutic modality for malignant gliomas.
